 MINNEAPOLIS, MN, Aug. 13, 2021 GLOBE NEWSWIRE -- PetVivo Holdings, Inc. Nasdaq: PETV, PETVW PetVivo or the Company, an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and therapeutics for pets, today closed its previously announced underwritten public offering of 2,500,000 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock. Each unit was sold to the public at a price of 4.50. The gross proceeds to the Company from the offering were approximately 11.25 million before deducting underwriting discounts, commissions and other offering expenses. The warrants will have a per share exercise price of 5.625, are exercisable immediately, and expire five years from the date of issuance. 